H.R. 2005 (119th)Bill Overview

DMEPOS Relief Act of 2025

Health|Health
Cosponsors
Support
Lean Republican
Introduced
Mar 10, 2025
Discussions
Bill Text
Current stageCommittee

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for c…

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

This bill (DMEPOS Relief Act of 2025) directs the HHS Secretary to apply the transition rule in 42 C.F.R. §414.210(g)(9)(v) to applicable durable medical equipment items formerly in the 2021 DMEPOS competitive bidding round for areas other than rural or noncontiguous areas through December 31, 2025. It also prohibits implementation of 42 C.F.R. §414.210(g)(9)(vi) until January 1, 2026, and authorizes the Secretary to implement these provisions by program instruction or other means.

Why people may split

Liberals stress beneficiary access and supplier stability

Watch point

Relative to its intended legislative type, this bill is a narrowly targeted substantive policy change that clearly directs the Secretary of HHS to apply and defer specified regulatory provisions governing Medicare DMEPOS payments, with clear dates and authority for implementation via program instruction.

This bill (DMEPOS Relief Act of 2025) directs the HHS Secretary to apply the transition rule in 42 C.F.R. §414.210(g)(9)(v) to applicable durable medical equipment items formerly in the 2021 DMEPOS competitive bidding round for areas other than rural or noncontiguous areas through December 31, 2025.

It also prohibits implementation of 42 C.F.R. §414.210(g)(9)(vi) until January 1, 2026, and authorizes the Secretary to implement these provisions by program instruction or other means.

Passage40/100

Technocratic, time-limited Medicare payment adjustment has modest chances—likely to succeed if bundled into a larger legislative vehicle; standalone passage less certain.

CredibilityPartially aligned

Relative to its intended legislative type, this bill is a narrowly targeted substantive policy change that clearly directs the Secretary of HHS to apply and defer specified regulatory provisions governing Medicare DMEPOS payments, with clear dates and authority for implementation via program instruction. It integrates explicitly with existing regulatory text but omits fiscal acknowledgment, reporting, and contingency language.

Contention60/100

Liberals stress beneficiary access and supplier stability

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Likely helpedLikely burdened

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Potential benefitStabilizes Medicare payment rates for certain DME suppliers through the end of 2025.
  • Potential benefitReduces the likelihood of sudden revenue drops for suppliers previously in the 2021 bidding round.
  • Potential benefitHelps maintain beneficiary access to durable medical equipment by supporting supplier participation.
Likely burdened
  • Potential burdenLikely increases Medicare outlays compared with immediate implementation of lower competitive-bid rates.
  • Potential burdenCreates unequal treatment between areas by applying the transition for some locations only.
  • Potential burdenMay delay market incentives for price competition and efficiency among DME providers.
03 · Why people split

Why the argument around this bill splits.

Liberals stress beneficiary access and supplier stability
Progressive85%

Likely supportive as a near-term protection for beneficiaries and small suppliers facing payment cuts from competitive bidding changes.

Would view the bill as a pragmatic pause to prevent service disruptions while seeking longer-term solutions that preserve access.

Leans supportive
Centrist65%

Generally supportive of a temporary, administrative pause to avoid provider disruption, but seeks cost estimates and clarity.

Would favor tying the pause to data and ensuring the pause is narrowly tailored and time-limited.

Split reaction
Conservative35%

Skeptical because it delays implementation of competitive bidding rules that aim to reduce Medicare spending.

Some conservatives might accept a brief administrative delay to avoid immediate disruptions, but many will oppose undermining market-based rate-setting.

Likely resistant
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood40/100

Technocratic, time-limited Medicare payment adjustment has modest chances—likely to succeed if bundled into a larger legislative vehicle; standalone passage less certain.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • No cost estimate or Congressional Budget Office score included
  • Degree of supplier/provider support or opposition unknown
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Liberals stress beneficiary access and supplier stability

Technocratic, time-limited Medicare payment adjustment has modest chances—likely to succeed if bundled into a larger legislative vehicle; s…

Unlocked analysis

Relative to its intended legislative type, this bill is a narrowly targeted substantive policy change that clearly directs the Secretary of HHS to apply and defer specified regulatory provisions governing Medicare DMEPO…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis